A phase II study of intravenous T900607-sodium in subject with previously treated ovarian cancer
-
Investigator: Lisa Chen, MD
Sponsor: Tularik Inc.
Location(s): United States
Description
The purpose of this study is to determine whether T900607-sodium is effective and safe in treating ovarian cancer.